HIV
2,104
199
294
1,360
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
397 trials with published results (19%)
Research Maturity
1360 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.5%
73 terminated out of 2104 trials
94.9%
+8.4% vs benchmark
14%
286 trials in Phase 3/4
29%
397 of 1360 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1360 completed trials
Clinical Trials (2104)
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, Kenya
Natural History Study of Kaposi Sarcoma
Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Smoking Cessation Program for Lao People With HIV
B-PaLMZ for TB Meningitis
Reducing Stigma and Building Employability Skills for Young People With HIV in Zambia
PrEP (Pre-exposure Prophylaxis) Stigma and Women Ethnodrama Pre-Test Phase
Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
National Rapid TLC: Testing and Linkage to Care
Physical Activity for PLWH and Unhealthy Drinking
PrEP (Pre-exposure Prophylaxis) Stigma and Women Ethnodrama Pilot Phase
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
Telehealth for Pain and Unhealthy Drinking Among PLWH
SHARE Project Define
Digital PrEP Micro-Intervention for PWUD in Kazakhstan
Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2
People & Place: Impacts on Substance Use and HIV Outcomes in Los Angeles
Platform Trial For Cryptococcal Meningitis (PLATFORM-CM)